Vijay Balakumar
About Vijay Balakumar
Data last updated:
Vijay Balakumar is a Director at Steril-Gene Life Sciences Private Limited (since 2023), Director at Madras Pharma Holdings Private Limited (since 2019) and Director at Sunberg Life Sciences Private Limited (since 2016). The companies operate in Pharma and Financial Services. The 3 current companies with reported revenue have a combined latest revenue of ₹472 Cr; the largest is Steril-Gene Life Sciences Private Limited at ₹404 Cr (FY 2025). Earlier, Vijay Balakumar was a Whole-Time Director at Softgel Healthcare Private Limited (2018–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Steril-Gene Life Sciences Private Limited U02423TN2007PTC062549 | Director | 14 Dec 2023 | 2007 | ₹404 Cr (FY 2025) | Active |
 Madras Pharma Holdings Private Limited U65990TN2010PTC075670 | Director | 17 Aug 2019 | 2010 | ₹43.68 Cr (FY 2025) | Active |
| Sunberg Life Sciences Private Limited U51397TN2015PTC099067 | Director | 12 Sep 2016 | 2015 | ₹24.43 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Softgel Healthcare Private Limited U24231TN2003PTC051829 | Whole-Time Director | 01 Aug 2018 | 2003 | ₹327 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vijay Balakumar
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vijay Balakumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vijay Balakumar
Vijay Balakumar currently holds 3 directorships: Steril-Gene Life Sciences Private Limited (Director, since 14 Dec 2023, revenue ₹404 Cr (FY 2025)); Madras Pharma Holdings Private Limited (Director, since 17 Aug 2019, revenue ₹43.68 Cr (FY 2025)); Sunberg Life Sciences Private Limited (Director, since 12 Sep 2016, revenue ₹24.43 Cr (FY 2025)).
Vijay Balakumar was first appointed on 12 Sep 2016 as Director at Sunberg Life Sciences Private Limited. The most recent appointment on record is 14 Dec 2023 at Steril-Gene Life Sciences Private Limited.
The 3 current companies of Vijay Balakumar that report revenue have a combined latest revenue of ₹472 Cr: Steril-Gene Life Sciences Private Limited ₹404 Cr (FY 2025); Madras Pharma Holdings Private Limited ₹43.68 Cr (FY 2025); Sunberg Life Sciences Private Limited ₹24.43 Cr (FY 2025).
Vijay Balakumar held 1 earlier board appointment: Softgel Healthcare Private Limited (Whole-Time Director, 01 Aug 2018 to 08 Sep 2022).
The current boards of Vijay Balakumar's companies include Alagappan (Steril-Gene Life Sciences Private Limited), Chanpreet Singh Anand (Steril-Gene Life Sciences Private Limited), Dennis Dizon Balajadia (Steril-Gene Life Sciences Private Limited), Dick Dizon Balajadia (Steril-Gene Life Sciences Private Limited), Lloyd Dizon Balajadia (Steril-Gene Life Sciences Private Limited), Manohar Srivignesh (Steril-Gene Life Sciences Private Limited), among others.